Bayesian Capital Management’s Clarivate CLVT Stock Holding History

Bayesian Capital Management’s Portfolio CLVT Stock Details CLVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-23,000	Closed	-$88.1K	–	198
2025 Q3	$88.1K	Buy	+23,000	New	+$96.6K	0.02%	492
2024 Q1	–	Sell	-14,830	Closed	-$137K	–	816
2023 Q4	$137K	Buy	+14,830	New	+$110K	0.01%	642
2023 Q3	–	Sell	-47,700	Closed	-$455K	–	734
2023 Q2	$455K	Sell	47,700 -131,600	-73%	-$1.12M	0.05%	427
2023 Q1	$1.68M	Buy	+179,300	New	+$1.85M	0.21%	141
2022 Q3	–	Sell	-46,252	Closed	-$641K	–	739
2022 Q2	$641K	Buy	46,252 +33,052	+250%	+$494K	0.12%	261
2022 Q1	$221K	Buy	+13,200	New	+$219K	0.03%	625

Other funds holding CLVT

LGP

Leonard Green & Partners Los Angeles, California $962M AUM 35.11% 1-Year Est. Return

ENV

Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return

CCP

Clarkston Capital Partners Rochester, Michigan $1.18B AUM 0.37% 1-Year Est. Return

Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return

PGH

Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Atairos Group Bryn Mawr, Pennsylvania $1.76B AUM 16.47% 1-Year Est. Return

Bayesian Capital Management's CLVT Position: Q4 2025 in Review

Bayesian Capital Management sold out of Clarivate (CLVT) in Q4 2025, closing a stake of 23,000 shares — an estimated $88.1K sold.

Bayesian Capital Management first reported a position in CLVT in Q1 2022 and held it in 6 quarters. The position peaked at $1.68M in Q1 2023. 218 funds tracked by Wall St. Rank hold CLVT as of Q4 2025.

Bayesian Capital Management reported no remaining Clarivate position as of Q4 2025 after selling out during the quarter.
Bayesian Capital Management sold 23,000 Clarivate shares in Q4 2025, an estimated $88.1K.
Bayesian Capital Management first reported a position in Clarivate in Q1 2022 and held it in 6 quarters.
Bayesian Capital Management's Clarivate position peaked at $1.68M in Q1 2023.
218 funds tracked by Wall St. Rank held Clarivate as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.